IP Library Granted Patent US 7,787,949
Granted Patent B2
US 7,787,949 · App. 11/554,431 · Granted Aug 31, 2010

Biological pacemaker compositions and systems incorporating interstitial cells of Cajal

Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,787,949
App. No.
11/554,431
Granted
Aug 31, 2010
Kind
B2
Abstract

A biological pacemaker composition for implantation into cardiac tissue includes an effective amount of interstitial cells of Cajal (ICC) to produce or conduct pacing stimuli and thereby modulate cardiac contraction. The biological pacemaker may be included as part of a heart pacing system that includes an implantable electric pacemaker for producing backup pacing stimuli if the at least one biological pacemaker is unable to modulate cardiac contraction at a predetermined pacing rate. Methods for preventing cardiac pacing or conduction dysfunction in a heart include implanting the biological pacemaker or the heart pacing system into the heart.

Claims (10)

1. A method for preventing cardiac pacing or conduction dysfunction in a heart, comprising the steps of:

implanting into cardiac tissue a biological pacemaker comprising a preparation of an effective amount of interstitial cells of Cajal (ICC) to produce or conduct pacing stimuli and thereby modulate cardiac contraction.

2. The method according to claim 1 , wherein the step of implanting the biological pacemaker comprises implanting autologous ICC.

3. The method according to claim 1 , wherein the step of implanting the biological pacemaker comprises implanting at least one class of cells selected from the group consisting of myoblasts, hematopoietic stem cells, and bone marrow stem cells.

4. The method according to claim 3 , wherein the at least one class of cells comprises myoblasts.

5. The method according to claim 1 , wherein the step of implanting the biological pacemaker comprises implanting an effective amount of ICC to improve action potential conduction in the heart.

6. The method according to claim 3 , wherein the step of implanting the biological pacemaker comprises implanting autologous ICC.

7. The method according to claim 3 , wherein the step of implanting the biological pacemaker comprises implanting an effective amount of ICC to improve action potential conduction in the heart.

8. The method according to claim 4 , wherein the step of implanting the biological pacemaker comprises implanting autologous ICC.

9. The method according to claim 4 , wherein the step of implanting the biological pacemaker comprises implanting an effective amount of ICC to improve action potential conduction in the heart.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2006
From: XIAO, YONG-FU
To: MEDTRONIC, INC.
Reel/Frame 018457/0171 →
Continuity (1)
Related Publication 20080103536A1 · May 1, 2008